Compare Enzyme (MLN) vs Scallop (SCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Scallop — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Scallop trades at Rp119.79 (market cap Rp24,21M, Rp19,2M 24h volume). The key difference: Enzyme is far larger — about 5.5× Scallop's market cap, and Scallop's supply is capped (160,8M / 250M SCA (65%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Scallop for 14 Days on average.
| MLN | SCA | |
|---|---|---|
Market Cap | Rp134,13M | Rp24,21M |
Volume (24h) | Rp104,56M | Rp19,2M |
Circulating Supply | 3,3M MLN | 160,8M / 250M SCA (65%) |
Typical Hold Time | 29 Days | 14 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Scallop (SCA) shows limited market activity with a modest market cap of Rp24.21M and 65% circulating supply. The token exhibits low trading volumes and minimal price discovery, trading near recent lows with weak momentum. Recent news suggests some institutional interest through ETF exposure, but on-chain activity remains subdued with a 14-day average hold time indicating cautious investor behavior.
Outlook remains cautious due to low liquidity and limited ecosystem development. Key opportunity lies in potential ETF-driven exposure, while major risks include extreme volatility from low market depth and regulatory uncertainty in the crypto space. Investors should monitor exchange listings and protocol updates for catalysts.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Scallop
Scallop is an advanced decentralized finance (DeFi) protocol built on the Sui blockchain. It offers a wide range of financial services, including lending, borrowing, automated market making (AMM), and asset management. Developed by Scallop Labs, which has a team of experts in DeFi, cybersecurity, and fintech, Scallop has attracted support from notable investors such as CMS Holdings, 6th Man Ventures, KuCoin Labs, and Mysten Labs. Additionally, it is the first DeFi project to receive an official grant from the Sui Foundation, highlighting its institutional-grade quality and strong security features.
Read more on SCA →
